Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia

被引：0
|
作者：
M. Taj
M. Nadeem
S. Maqsood
T. Shah
T. Farzana
T. S. Shamsi
机构：
[1] National Institute of Blood Disease and Bone Marrow Transplantation,Department of Clinical Hematology and Bone Marrow Transplantation
[2] National Institute of Blood Disease and Bone Marrow Transplantation,Head of Clinical Laboratories
[3] National Institute of Blood Disease and Bone Marrow Transplantation,Department of Research and Development
来源：
Indian Journal of Hematology and Blood Transfusion | 2017年 / 33卷
关键词：
MASCC score; Hematological disorders; High-risk febrile neutropenia; Low-risk febrile neutropenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：355 / 360
页数：5
相关论文
共 50 条
  • [1] Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
    Taj, M.
    Nadeem, M.
    Maqsood, S.
    Shah, T.
    Farzana, T.
    Shamsi, T. S.
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (03) : 355 - 360
  • [2] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Kyung Soo Lim
    Jae-Lyun Lee
    [J]. Supportive Care in Cancer, 2013, 21 : 2303 - 2308
  • [3] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lim, Kyung Soo
    Lee, Jae-Lyun
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (08) : 2303 - 2308
  • [4] The predictive value of the MASCC score in patients with febrile neutropenia
    Anderson, Zackary
    Plowman, Keegan
    Ahsan, Mohammed
    Rasnake, Mark
    Kubiak, Michal J.
    Grossman, Joel Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Febrile neutropenia - an approach to outpatient therapy - prospective validation of the MASCC score for low-risk patients
    Gomes, FMR
    Marques, AMS
    Costa, FAO
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 294 - 294
  • [6] EARLY AMBISOME IN FEBRILE NEUTROPENIA IN PATIENTS WITH HEMATOLOGICAL DISORDERS
    GOLDSTONE, AH
    ODRISCOLL, A
    [J]. BONE MARROW TRANSPLANTATION, 1994, 14 : S15 - S17
  • [7] Prognosis prediction of febrile neutropenia by MASCC score: A retrospective study
    Cervetti, Louise
    Vallard, Alexis
    Le Moulec, Sylvestre
    Espenel, Sophie
    Falk, Alexander Tuan
    Ben Mrad, Majed
    Guy, Jean-Baptiste
    Diao, Peng
    Mery, Benoite
    Langrand-Escure, Julien
    Ferrand, Francois-Regis
    Rivoirard, Romain
    Ceccaldi, Bernard
    Vedrine, Lionel
    Magne, Nicolas
    Chargari, Cyrus
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : 561 - 570
  • [8] Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy
    O'Neal, Richard
    Roberts, Kandice
    Chen, Quan
    Huang, Bin
    Saeed, Hayder
    Ramlal, Reshma
    Monohan, Gregory
    Hildebrandt, Gerhard C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [9] Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score
    Aagaard, Theis
    Roen, Ashley
    Reekie, Joanne
    Daugaard, Gedske
    Brown, Peter de Nully
    Specht, Lena
    Sengelov, Henrik
    Mocroft, Amanda
    Lundgren, Jens
    Helleberg, Marie
    [J]. JNCI CANCER SPECTRUM, 2018, 2 (04)
  • [10] Effect of serum uric acid (ua) level and MASCC risk score on febrile neutropenia mortality
    Sutcuoglu, O.
    Akdogan, O.
    Inci, B. Kurt
    Gurler, F.
    Yildirim, N. Ozdemir
    Yazici, O.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1055 - S1055
12345